| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Common Clinical Dilemma: Management of Persistent hrHPV Infection
|
Meng, Yifan
|
|
2017
|
|
5 |
p. 315-318
|
artikel
|
| 2 |
ADAR and Immune Silencing in Cancer
|
Herbert, Alan
|
|
2019
|
|
5 |
p. 272-282
|
artikel
|
| 3 |
Advisory Board and Contents
|
|
|
|
|
5 |
p. i-ii
|
artikel
|
| 4 |
Advisory Board and Contents
|
|
|
|
|
5 |
p. i-ii
|
artikel
|
| 5 |
Advisory Board and Contents
|
|
|
|
|
5 |
p. i
|
artikel
|
| 6 |
Advisory Board and Contents
|
|
|
|
|
5 |
p. i
|
artikel
|
| 7 |
A Molecular Take on Malignant Rhabdoid Tumors
|
Tang, Ming
|
|
2016
|
|
5 |
p. 217-218
|
artikel
|
| 8 |
A specialist-generalist framework for epithelial-mesenchymal plasticity in cancer
|
Cook, David P.
|
|
|
|
5 |
p. 358-368
|
artikel
|
| 9 |
Beyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy
|
Baillie, Katherine E.
|
|
|
|
5 |
p. 430-446
|
artikel
|
| 10 |
Building Diverse Mentoring Networks that Transcend Boundaries in Cancer Research
|
Termini, Christina M.
|
|
|
|
5 |
p. 385-388
|
artikel
|
| 11 |
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
|
Lengyel, Ernst
|
|
2018
|
|
5 |
p. 374-384
|
artikel
|
| 12 |
Cancer CRISPR Screens In Vivo
|
Chow, Ryan D.
|
|
2018
|
|
5 |
p. 349-358
|
artikel
|
| 13 |
Cancer Immunotherapy with CDK7 Inhibitors
|
Petroni, Giulia
|
|
|
|
5 |
p. 361-363
|
artikel
|
| 14 |
Cancer of Unknown Primary in the Molecular Era
|
Kato, Shumei
|
|
|
|
5 |
p. 465-477
|
artikel
|
| 15 |
Cell and Tissue Biology Paves a Path to Breast Cancer Prevention
|
Todhunter, Michael E.
|
|
2017
|
|
5 |
p. 313-315
|
artikel
|
| 16 |
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy
|
Knudsen, Erik S.
|
|
2019
|
|
5 |
p. 308-324
|
artikel
|
| 17 |
Cell death, therapeutics, and the immune response in cancer
|
Hänggi, Kay
|
|
|
|
5 |
p. 381-396
|
artikel
|
| 18 |
Coagulome and the tumor microenvironment: an actionable interplay
|
Galmiche, Antoine
|
|
|
|
5 |
p. 369-383
|
artikel
|
| 19 |
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
|
Jiang, Ming-jie
|
|
|
|
5 |
p. 419-431
|
artikel
|
| 20 |
Development versus Evolution in Cancer Biology
|
Marongiu, Fabio
|
|
2018
|
|
5 |
p. 342-348
|
artikel
|
| 21 |
DUX4 Pathological Expression: Causes and Consequences in Cancer
|
Dib, Carla
|
|
2019
|
|
5 |
p. 268-271
|
artikel
|
| 22 |
Dynamic immune signatures as biomarkers for irAEs
|
Yang, Jingwen
|
|
|
|
5 |
p. 379-380
|
artikel
|
| 23 |
Editorial Board and Contents
|
|
|
2016
|
|
5 |
p. i
|
artikel
|
| 24 |
Editorial Board and Contents
|
|
|
2017
|
|
5 |
p. i
|
artikel
|
| 25 |
Editorial Board and Contents
|
|
|
2019
|
|
5 |
p. i
|
artikel
|
| 26 |
Editorial Board and Contents
|
|
|
2018
|
|
5 |
p. i
|
artikel
|
| 27 |
Elevated circulating memory T cells precede immunotherapy toxicities in melanoma
|
Bello, Elisa
|
|
|
|
5 |
p. 347-349
|
artikel
|
| 28 |
Emerging Role of mTOR in the Response to Cancer Therapeutics
|
Ilagan, Erika
|
|
2016
|
|
5 |
p. 241-251
|
artikel
|
| 29 |
Emerging signaling mediators in the anorexia–cachexia syndrome of cancer
|
Talbert, Erin E.
|
|
|
|
5 |
p. 397-403
|
artikel
|
| 30 |
Endoplasmic Reticulum Stress and the Hallmarks of Cancer
|
Urra, Hery
|
|
2016
|
|
5 |
p. 252-262
|
artikel
|
| 31 |
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity
|
Wainwright, Elanor N.
|
|
2017
|
|
5 |
p. 372-386
|
artikel
|
| 32 |
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
|
Arpinati, Ludovica
|
|
|
|
5 |
p. 421-443
|
artikel
|
| 33 |
Gluconeogenesis of Cancer Cells Is Disrupted by Citrate
|
Icard, Philippe
|
|
2019
|
|
5 |
p. 265-266
|
artikel
|
| 34 |
GSDME: A Potential Ally in Cancer Detection and Treatment
|
Ibrahim, J.
|
|
|
|
5 |
p. 392-394
|
artikel
|
| 35 |
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
|
Calses, Philamer C.
|
|
2019
|
|
5 |
p. 297-307
|
artikel
|
| 36 |
HLA-G/LILRBs: A Cancer Immunotherapy Challenge
|
Carosella, Edgardo D.
|
|
|
|
5 |
p. 389-392
|
artikel
|
| 37 |
Human Papillomaviruses: Research Priorities for the Next Decade
|
Langsfeld, Erika
|
|
2016
|
|
5 |
p. 234-240
|
artikel
|
| 38 |
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
|
Fucikova, Jitka
|
|
|
|
5 |
p. 426-444
|
artikel
|
| 39 |
Improved Pathological Examination of Tumors with 3D Light-Sheet Microscopy
|
Uhlén, Per
|
|
2018
|
|
5 |
p. 337-341
|
artikel
|
| 40 |
Interplay between K-RAS and miRNAs
|
Shui, Bing
|
|
|
|
5 |
p. 384-396
|
artikel
|
| 41 |
Intestinal stem cell dynamics in homeostasis and cancer
|
Ramadan, Rana
|
|
|
|
5 |
p. 416-425
|
artikel
|
| 42 |
Intrinsic Molecular Processes: Impact on Mutagenesis
|
Lim, Byungho
|
|
2017
|
|
5 |
p. 357-371
|
artikel
|
| 43 |
Leveraging histone glycation for cancer diagnostics and therapeutics
|
Knörlein, Anna
|
|
|
|
5 |
p. 410-420
|
artikel
|
| 44 |
Low tumor mutational burden and immunotherapy in gliomas
|
Brown, Michael C.
|
|
|
|
5 |
p. 345-346
|
artikel
|
| 45 |
Mapping Effector–Phenotype Landscapes in KRAS-Driven Cancers
|
Winter, Peter S.
|
|
2018
|
|
5 |
p. 333-335
|
artikel
|
| 46 |
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?
|
André, Nicolas
|
|
2017
|
|
5 |
p. 319-325
|
artikel
|
| 47 |
MGMT Status as a Clinical Biomarker in Glioblastoma
|
Butler, Madison
|
|
|
|
5 |
p. 380-391
|
artikel
|
| 48 |
Molecular Events in the Natural History of Pancreatic Cancer
|
Oldfield, Leslie E.
|
|
2017
|
|
5 |
p. 336-346
|
artikel
|
| 49 |
New Therapies in Head and Neck Cancer
|
Santuray, Rodell T.
|
|
2018
|
|
5 |
p. 385-396
|
artikel
|
| 50 |
N of 1 Data Sharing: The Impact of Data Sharing within the Hematology–Oncology Drug Products Division of the US FDA
|
Gill, Jennifer
|
|
|
|
5 |
p. 395-399
|
artikel
|
| 51 |
Noninvasive PET Imaging of T cells
|
Wei, Weijun
|
|
2018
|
|
5 |
p. 359-373
|
artikel
|
| 52 |
On a New Proposed Mechanism of 5-Fluorouracil-Mediated Cytotoxicity
|
Hussain, Shobbir
|
|
|
|
5 |
p. 365-368
|
artikel
|
| 53 |
Oncohistones in brain tumors: the soil and seed
|
Andrade, Augusto Faria
|
|
|
|
5 |
p. 444-455
|
artikel
|
| 54 |
Palmitate paves the way to lung metastasis
|
Winkelkotte, Alina M.
|
|
|
|
5 |
p. 376-378
|
artikel
|
| 55 |
Pediatric Cancer Models in Zebrafish
|
Casey, Mattie J.
|
|
|
|
5 |
p. 407-418
|
artikel
|
| 56 |
Plant-derived cannabinoids as anticancer agents
|
O’Reilly, Eve M.
|
|
|
|
5 |
p. 350-357
|
artikel
|
| 57 |
Plastic Heterogeneity of Innate Lymphoid Cells in Cancer
|
Wagner, Marek
|
|
2017
|
|
5 |
p. 326-335
|
artikel
|
| 58 |
Probing Tumour Proteostasis and the UPR with Serum Markers
|
Galmiche, Antoine
|
|
2016
|
|
5 |
p. 219-221
|
artikel
|
| 59 |
Prolonging Reproductive Life after Cancer: The Need for Fertoprotective Therapies
|
Woodard, Terri L.
|
|
2016
|
|
5 |
p. 222-233
|
artikel
|
| 60 |
Promoter DNA Hypermethylation and Paradoxical Gene Activation
|
Smith, Jim
|
|
|
|
5 |
p. 392-406
|
artikel
|
| 61 |
Redox Debt Leads to Metabolic Bankruptcy in Tumors
|
Quon, Evan
|
|
|
|
5 |
p. 359-361
|
artikel
|
| 62 |
Re-Evaluating Clonal Dominance in Cancer Evolution
|
Burrell, Rebecca A.
|
|
2016
|
|
5 |
p. 263-276
|
artikel
|
| 63 |
Solid Stress in Brain Tumors
|
Gilkes, Daniele M.
|
|
2019
|
|
5 |
p. 266-268
|
artikel
|
| 64 |
Stem Cells, Cancer, and MUSASHI in Blood and Guts
|
Kharas, Michael G.
|
|
2017
|
|
5 |
p. 347-356
|
artikel
|
| 65 |
Subscription and Copyright Information
|
|
|
2019
|
|
5 |
p. 325
|
artikel
|
| 66 |
Subscription & copyright page
|
|
|
|
|
5 |
p. e1
|
artikel
|
| 67 |
Subscription & copyright page
|
|
|
|
|
5 |
p. e1
|
artikel
|
| 68 |
Subscription & copyright page
|
|
|
|
|
5 |
p. e1
|
artikel
|
| 69 |
Subscription & copyright page
|
|
|
|
|
5 |
p. e1
|
artikel
|
| 70 |
Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer
|
Nokin, Marie-Julie
|
|
|
|
5 |
p. 410-429
|
artikel
|
| 71 |
Targeting synthetic lethal paralogs in cancer
|
Ryan, Colm J.
|
|
|
|
5 |
p. 397-409
|
artikel
|
| 72 |
The Mystery of Rap1 Suppression of Oncogenic Ras
|
Nussinov, Ruth
|
|
|
|
5 |
p. 369-379
|
artikel
|
| 73 |
The unequal burden of time toxicity
|
Johnson, Whitney V.
|
|
|
|
5 |
p. 373-375
|
artikel
|
| 74 |
Transcriptional determinants of cancer immunotherapy response and resistance
|
Gupta, Romi
|
|
|
|
5 |
p. 404-415
|
artikel
|
| 75 |
Treating the Disease, Not the Symptom: Beyond NSAIDs
|
Bowers, Robert R.
|
|
|
|
5 |
p. 363-365
|
artikel
|
| 76 |
Tumor Plasticity and Resistance to Immunotherapy
|
Horn, Lucas A.
|
|
|
|
5 |
p. 432-441
|
artikel
|
| 77 |
Turning Cold Tumors Hot by Blocking TGF-β
|
Ros, Xavier Romero
|
|
2018
|
|
5 |
p. 335-337
|
artikel
|
| 78 |
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
|
Sieow, Brendan Fu-Long
|
|
|
|
5 |
p. 447-464
|
artikel
|
| 79 |
Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment
|
Gottlieb, Bruce
|
|
|
|
5 |
p. 400-409
|
artikel
|
| 80 |
YAP/TAZ Signaling and Resistance to Cancer Therapy
|
Nguyen, Chan D.K.
|
|
2019
|
|
5 |
p. 283-296
|
artikel
|
Tijdschrift beschrijving